Blood Tests for ALS Provide Highly Accurate Diagnosis and Prognosis

Head-to-head study shows four blood-based Neurofilament Light Chain assays reliably identify amyotrophic lateral sclerosis and forecast disease course without invasive procedures.

Topline

Recent research demonstrates that blood tests measuring serum neurofilament light chain (NfL) can accurately diagnose amyotrophic lateral sclerosis (ALS) and forecast patient survival, offering clinicians and patients valuable diagnostic and prognostic tools without invasive procedures.

Study Background

A study conducted in southern France, recentl…